期刊文献+

Flk-1265-2493与C3d3基因融合质粒诱导小鼠免疫应答的初步研究

Immunological effect of a DNA vaccine encoding genetic fusion of Flk-1_(265-2493) and three copies of C3d
下载PDF
导出
摘要 目的对pSG.SS.Flk-1265-2493.C3d3.YL及pSG.SS.Flk-1265-2493.YL真核表达质粒的免疫效应进行初步研究。方法构建pSG.SS.Flk-1265-2493.C3d3.YL及pSG.SS.Flk-1265-2493.YL真核表达质粒后,48只BALB/c小鼠随机均分为疫苗组、疫苗对照组、质粒对照组、空白对照组(12只/组),分别肌肉注射接种此2种质粒、pSG.SS.YL质粒和PBS。免疫后动物:①每组6只取脾脏分离细胞,MTT法测定经Flk-1蛋白刺激后的增殖效应,乳酸脱氢酶释放法测定对培养小鼠肺微血管内皮细胞的杀伤作用;②其余6只动物于不同时间点断尾取血分离血清,ELISA法测定抗Flk-1抗体水平的动态变化。结果经Flk-1蛋白刺激,疫苗组小鼠脾淋巴细胞的增殖效应明显较强,刺激指数显著高于其他3组(P均<0.01),对靶细胞(MVECs)的杀伤活性在不同效/靶比时均显著高于其他3组(P均<0.01)。疫苗组动物血清抗Flk-1抗体比对照疫苗组抗体阳性反应出现早2周,二者峰值效价均出现在5周(血清稀释度:1∶3840vs1∶60),前者12周时仍保持较高水平(1∶960),后者10周时抗体阳性反应已消失。结论C3d3的连接有效增强了Flk-1265-2493的免疫原性。 Objective To evaluate the immunological effect of eukaryotic expression plasmids pSG. SS. Flk-1265-2493. C3d3. YL and pSG. SS. Flk-1265-2493. YL. Mothods After construction of eukaryotic expression plasmids pSG. SS. Flk-1265-2493. C3d3. YL and pSG. SS. Flk-1265-2493. YL, BALB/c female mice (n =48) were separated into four groups (n = 12 per group) and were inoculated by intramuscular injection of the two plasraids, pSG. SS. YL plasmid (plasmid control) and PBS (blank control), respectively. After inoculation, proliferation of spleen lymphocytes stimulated with Flk-1 protein was studied using MTT method and the specific cytotoxieity T lymphocyte (CTL) effect on target cells (microvaseular endothelial cells, MVECs) was assayed with lactate dehydrogenase-release method. Then anti-Flk-1 antibody titers in the immune sera were assayed with indirect enzyme-linked immunosordent assay (ELISA). Results After stimulation with Flk-1 antigen, the proliferation and specific CTL activities of spleen lymphocytes in mice immunized with pSG. SS. Flk-1265-493. C3d3. YL were obviously stronger than those in other three groups. Although both plasmids could elicit Flk-1 specific antibody, in pSG. SS. Flk-1265-2493.C3d3. YL immunized mice, the antibody presented 2 weeks earlier, and the titer was significantly higher than that in mice immunized with pSG. SS. Flk-1265-2493. YL. Conclusion The results show that the C3d3 fusion strategy can enhance the immunogenicity of Flk-1 significantly
出处 《第三军医大学学报》 CAS CSCD 北大核心 2009年第13期1239-1242,共4页 Journal of Third Military Medical University
基金 国家自然科学基金(30571864)~~
关键词 血管新生 DNA疫苗 FLK-1 C3D angiogenesis DNA vaccine Flk-1 C3d
  • 相关文献

参考文献16

  • 1Hou J M, Liu J Y, Yang L, et al. Combination of low-dose gemcitabine and recombinant quail vascular endothelial growth factor receptor- 2 as a vaccine induces synergistic antitumor activities[ J]. Ontology, 2005, 69(1) : 81 -87. 被引量:1
  • 2许桂莲,姜曼,郭波,吕燕波,邹丽云,费蕾,黄云辉,陈永文,牟芝蓉,吴玉章.FLK1_(265-2493)与C3d3融合基因真核表达质粒的构建及表达[J].免疫学杂志,2006,22(3):280-282. 被引量:3
  • 3徐顺贵,吴国明,徐智,冯起甲,王关嵩,张健鹏.组织块法培养大鼠肺微血管内皮细胞的综合鉴定[J].第三军医大学学报,2007,29(1):39-42. 被引量:21
  • 4沈关心 周汝麟主编.现代免疫学实验技术[M]:第2版[M].武汉:湖北科学技术出版社,2002.1-5. 被引量:3
  • 5Fernando NT, Koch M, Rothrock C, et al. Tumor escape from endogenous, extracenular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors [ J ]. Clin Cancer Res, 2008, 14(5) :1529 - 1539. 被引量:1
  • 6Dempsey P W, Allison M E, Akkaraju S, et al. C3d of complement as a molecular adjuvant : bridging innate and acquired immunity[ J]. Science, 1996, 271(5247): 348-350. 被引量:1
  • 7Liu F, Mboudjeka I, Shen S, et al. Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gp120 glycoprotein by codon optimization and C3d fusion in a mouse model[J]. Vaccine, 2004,22( 13 - 14) :1764 - 1772. 被引量:1
  • 8Fan H, Tong T, Chen H, et al. hnmunization of DNA vaccine encoding C3d-VPI fusion enhanced protective immune response against foot- and-mouth disease virus [ J ]. Virus Genes, 2007,35 (2) :347 - 357. 被引量:1
  • 9Bergmann-Leitner E S, Duncan E H, Leitner W W, et al. C3d-defined complement receptor-binding peptide p28 conjugated to circumsporozoite protein provides protection against Plasmodium berghei [ J ]. Vaccine, 2007, 25 ( 45 ) :7732 - 7736. 被引量:1
  • 10Green T D, Newton B R, Rata P A, et al. C3d enhancement of neutralizing antibodies to measles hemagglutinin[J]. Vaccine, 2001,20 ( 1 - 2 ) : 242 - 248. 被引量:1

二级参考文献15

  • 1Bikfalvi A, Bicknell R. Recent advances in angiogenesis,anti-angiogenesis and vascular targeting[J]. Trends Pharmacol Sci, 2002, 23 (12) : 576 - 582. 被引量:1
  • 2Shibuya M. Angiogenesis,anti-angiogenesis, and tumor suppression[J]. Nippon Yakurigaku Zasshi, 2002, 120 (5): 285-294. 被引量:1
  • 3Niethammer AG, Xiang R, Becker JC, et al. A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth [ J ]. Nat Med, 2002, 8 ( 12 ) :1 369- 1 375. 被引量:1
  • 4Liu JY, Wei YQ, Yang L, et al. Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2[J]. Blood, 2003,102 (5) : 1 815 -1 823. 被引量:1
  • 5Watanabe I, Ross TM, Tamura S, et al. Protection against influenza virus infection by intranasal administration of C3dfused hemagglutinin[J]. Vaccine, 2003, 21(31): 4 532- 4 538. 被引量:1
  • 6Wang L, Sunyer JO, Bello LJ. Fusion to C3d enhances the immunogenicity of the E2 glycoprotein of type 2 bovine viral diarrhea virus[J]. J Virol, 2004, 78(4) : 1 616 - 1 622. 被引量:1
  • 7Shinkai A, Ito M, Anazawa H, et al. Mapping of the sites involved in ligand association and dissociation at the extracelluar domain of the kinase insert domain-containing receptor of vascular endothelial growth factor[J]. J Biol Chem, 1998,273 (47): 31 283-31 288. 被引量:1
  • 8Lu D, Kussie P, Pytowski B, et al. Identification of the residues in the extracellular region of KDR important for interaction with vascular endothelial growth factor and neutralizing anti-KDR antibodies[J]. J Biol Chem, 2000, 275 (19):14 321 - 14 330. 被引量:1
  • 9Green TD, Montefiori DC, Ross TM. Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d[ J ]. J Virol, 2003,77(3) : 2 046 - 2 055. 被引量:1
  • 10Chi J T, Chang H Y, Haraldsen G, et al. Endothelial cell diversity revealed by global expression profiling[ J]. Proc Natl Acad Sci U S A,2003, 100(19) : 10623 - 10628. 被引量:1

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部